Breakout Stocks of Week 15 @ GER
NASDAQ was down last week (week 14) by -0.799% ending at 16,248.52 points after falling -130.94 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Deutsche Börse Aktiengesellschaft GER:DB1. This stock has had a buy signal since Mar 19, 2024 when the price was 185.60€ and is so far up 0.781% to 187.05€. Some other companies are on our watchlist to, among these are which all got a breakout pattern emerging.
| Date | Company | Price | Week 15 |
|---|---|---|---|
| Deutsche Börse Aktiengesellschaft | 187.05€ | 189.70€ | 1.42% |
| Sma Solar Technology Ag | 49.50€ | 49.18€ | -0.646% |
The Deutsche Börse Aktiengesellschaft stock price gained 0.565% on the last trading day (Friday, 5th Apr 2024), rising from 186.00€ to 187.05€. During the last trading day the stock fluctuated 1.87% from a day low at 184.00€ to a day high of 187.45€. The price has risen in 7 of the last 10 days and is up by 1.05% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 66 thousand more shares were traded than the day before. In total, 399 thousand shares were bought and sold for approximately 74.61€ million.
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Deutsche Börse Aktiengesellschaft stock to perform well in the short-term period.
About Deutsche Börse Aktiengesellschaft:
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
The SMA Solar Technology AG stock price fell by -4.16% on the last day (Friday, 5th Apr 2024) from 51.65€ to 49.50€. During the last trading day the stock fluctuated 4.95% from a day low at 49.50€ to a day high of 51.95€. The price has been going up and down for this period, and there has been a -7.3% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -14 thousand shares and in total, 122 thousand shares were bought and sold for approximately 6.03€ million.
The SMA Solar Technology AG stock holds several negative signals and despite the positive trend, we believe SMA Solar Technology AG will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
About SMA Solar Technology AG:
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
